- Geopolitical situation and Red Sea disruptions led to supply chain delays
- Subdued overall demand in FY24, particularly in Japan market
Glenmark Life Sciences Limited
Greenhouse gas emissions & sustainability report data
In its 2023-04 to 2024-03 reporting, Glenmark Life Sciences Limited disclosed greenhouse gas emissions of 667.1K tCO2e/year (Scope 1). By scope: Scope 1: 667.1K tCO2e/year; Scope 2: 59.7K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
667.1K tCO2e/year (Scope 1)
2023-04 to 2024-03
Renewable Energy
9.18% of total energy use
of total energy
Water Usage
324.1K KL/year
2023-04 to 2024-03
Waste
13.2K MT/year
2023-04 to 2024-03
Energy Use
7.3M GJ/year
2023-04 to 2024-03
📊 Emissions by Scope (2023-04 to 2024-03)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 667.1K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 59.7K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 9.18% of electricity usage contributed from renewable energy sources
- Specific water consumption down by 42.59%
- 93,445 KL water recycled & reused
🎯 Climate & Sustainability Targets
🔜 Short-term
- Water neutrality by 2027
- Zero waste to landfill by 2027
📅 Medium-term
- Carbon neutrality by 2030
🌱 ESG Focus Areas
EnvironmentalSocialGovernance